Atara Biotherapeutics (ATRA) News
NASDAQ: ATRAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
6.33-0.01 (-0.16%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
ATRA news summary
We found 2 recent headlines mentioning Atara Biotherapeutics (ATRA): 0 in the past week and 1 in the past 30 days, most often from Business Wire, Nasdaq. For price context, ATRA is down 0.16% at $6.33. The most recent story, "Atara Biotherapeutics Announces Third Quarter 2026 Financial Results and Operational Progress", was published by Business Wire on Nov 10, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Atara Biotherapeutics headlines
- Atara Biotherapeutics Announces Third Quarter 2026 Financial Results and Operational ProgressTHOUSAND OAKS, Calif.--(BUSINESS WIRE)--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to…Business Wire
- 5 Biotech Stocks To Watch: Bluejay, Pharvaris, Roivant, PDSB & Atara(RTTNews) - Several biotech stocks were in focus Tuesday, including Bluejay Diagnostics following a federal healthcare partnership with Lovell Government Services; Pharvaris after positive Phase 3…NasdaqATRA, BJDX, PDSB, PHVS